Department of Chemistry, Stony Brook University , Stony Brook, New York.
Cancer Biother Radiopharm. 2018 Oct;33(8):308-315. doi: 10.1089/cbr.2018.2499. Epub 2018 Jul 13.
New, targeted imaging tracers enable improved diagnosis, staging, and planning of treatment of disease and represent an important step toward personalized medicine applications. The combination of radioisotopes for nuclear imaging with fluorophores for fluorescence imaging provides the possibility to noninvasively assess disease burden in a patient using positron emission tomography/single-photon emission computed tomography, followed by fluorescence imaging-assisted surgical intervention in close succession. Probes enabling imaging with both modalities pose a design, synthesis, and pharmacokinetics challenge. In this study, the authors strive to summarize recent efforts toward optimized, discrete, bimodal probes as well as a perspective on future directions of this burgeoning subfield of targeted imaging probe development.
新型靶向成像示踪剂可改善疾病的诊断、分期和治疗计划,是迈向个体化医疗应用的重要一步。放射性核素用于正电子发射断层扫描/单光子发射计算机断层扫描的核医学成像与荧光团用于荧光成像的结合,为使用正电子发射断层扫描/单光子发射计算机断层扫描非侵入性地评估患者的疾病负担提供了可能性,随后紧接着进行荧光成像辅助的手术干预。能够同时进行两种模式成像的探针提出了设计、合成和药代动力学方面的挑战。在这项研究中,作者努力总结了最近在优化、离散、双模态探针方面的努力,并对这一靶向成像探针开发的新兴子领域的未来方向进行了展望。